Pneumology - Original Articles
26 June 2025
Early Access
Study of the clinical profile of community-acquired pneumonia: a cross-sectional study in northeast India
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
0
Views
0
Downloads
Authors
Community-acquired pneumonia (CAP) continues to pose a significant public health burden in India, particularly in the northeastern region, where data on microbial etiology and resistance patterns remain scarce. This cross-sectional observational analytical study, conducted over one year at a tertiary care center in northeast India, analyzed 117 adult patients with clinico-radiologically confirmed CAP to elucidate their clinical, epidemiological, and microbiological profiles. The cohort was predominantly male (76.9%), with a mean age of 52 years, and the most affected age group was 31-40 years. Hypertension and chronic obstructive pulmonary disease were the most common comorbidities. Cough, breathlessness, and fever were the leading symptoms. Sputum cultures were positive in 42.7% of cases, with a striking predominance of gram-negative organisms (94%), especially Klebsiella pneumoniae and Pseudomonas species. Alarmingly, high resistance rates were observed for widely used antibiotics such as ceftriaxone and cefuroxime, while meropenem, amikacin, and ertapenem retained high sensitivity. These findings emphasize the critical need for tailored, region-specific empirical treatment strategies in light of emerging antibiotic resistance trends in CAP.
Altmetrics
Downloads
Download data is not yet available.
Citations
Ishida T, Hashimoto T, Arita M, et al. Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. Chest 1998;114:1588-93. DOI: https://doi.org/10.1378/chest.114.6.1588
Lim WS, Baudouin SV, George RC, et al. Pneumonia guidelines committee of the BTS standards of care committee. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009;64:iii1-55. DOI: https://doi.org/10.1136/thx.2009.121434
Lim WS. Pneumonia—overview. Encyclopedia of Respiratory Medicine 2021:185-97. DOI: https://doi.org/10.1016/B978-0-12-801238-3.11636-8
Bartlett JG, Breiman RF, Mandell LA, File TM Jr. Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America. Clin Infect Dis 1998;26:811-38. DOI: https://doi.org/10.1086/513953
Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996;275:134-41. DOI: https://doi.org/10.1001/jama.1996.03530260048030
Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995;333:1618-24. DOI: https://doi.org/10.1056/NEJM199512143332408
Ombelet S, Barbé B, Affolabi D, et al. Best practices of blood cultures in low- and middle-income countries. Front Med 2019;6:131. DOI: https://doi.org/10.3389/fmed.2019.00131
Bayot ML, Bragg BN. Antimicrobial susceptibility testing. Treasure Island, FL, USA: StatPearls Publishing; 2025.
Clinical and Laboratory Standards Institute. CLSI standards: guidelines for health care excellence. 2011. Available from: https://www.ncbi.nlm.nih.gov/books/NBK544376/
Mahendra M, Jayaraj BS, Limaye S, et al. Factors influencing severity of community-acquired pneumonia. Lung India 2018;35:284-9. DOI: https://doi.org/10.4103/lungindia.lungindia_334_17
Para RA, Fomda BA, Jan RA, et al. Microbial etiology in hospitalized North Indian adults with community-acquired pneumonia. Lung India 2018;35:108-15. DOI: https://doi.org/10.4103/lungindia.lungindia_288_17
Shah BA, Singh G, Naik MA, Dhobi GN. Bacteriological and clinical profile of Community acquired pneumonia in hospitalized patients. Lung India 2010;27:54-7. DOI: https://doi.org/10.4103/0970-2113.63606
Kalita D, Sarma RK, Sharma KR, Deka S. High proportion of drug-resistant isolates in adult community-acquired pneumonia from northeast India: a hospital-based study. Lung India 2021;38:460-5. DOI: https://doi.org/10.4103/lungindia.lungindia_978_20
Kanishan C, Shetty VA, Hampana S, et al. Bacterial aetiology of community acquired pneumonia in a tertiary care hospital of southern India. J Clin Diagn Res 2020;14:DC05-9. DOI: https://doi.org/10.7860/JCDR/2020/43262.13507
Menon RU, George AP, Menon UK. Etiology and anti-microbial sensitivity of organisms causing community acquired pneumonia: a single hospital study. J Family Med Prim Care 2013;2:244-9. DOI: https://doi.org/10.4103/2249-4863.120728
Abdullah BB, Zoheb M, Ashraf SM, et al. A study of community-acquired pneumonias in elderly individuals in Bijapur, India. ISRN Pulmonol 2012;2012:936790. DOI: https://doi.org/10.5402/2012/936790
Ashurst JV, Dawson A. Klebsiella Pneumonia. Treasure Island, FL, USA: StatPearls Publishing; 2025.
Bansal S, Kashyap S, Pal LS, Goel A. Clinical and bacteriological profile of community acquired pneumonia in Shimla, Himachal Pradesh. Indian J Chest Dis Allied Sci 2004;46:17-22.
Sharma R, Deoskar R, Bargaje M, et al. A study of etiological and clinical profile of community acquired pneumonia in a tertiary care hospital in Western India. Eu Respir J 2014;42:2766.
Prasad P, Bhat S. Clinicomicrobiological study of community-acquired pneumonia. Lung India 2017;34:491-2. DOI: https://doi.org/10.4103/lungindia.lungindia_89_17
Peto L, Nadjm B, Horby P, et al. The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review. Trans R Soc Trop Med Hyg 2014;108:326-37. DOI: https://doi.org/10.1093/trstmh/tru058
Goel N, Chaudhary U, Aggarwal R, Bala K. Antibiotic sensitivity pattern of gram negative bacilli isolated from the lower respiratory tract of ventilated patients in the intensive care unit. Indian J Crit Care Med 2009;13:148-51. DOI: https://doi.org/10.4103/0972-5229.58540
Dion CF, Ashurst JV. Streptococcus pneumoniae. Treasure Island, FL, USA: StatPearls Publishing; 2025.
Muteeb G, Rehman MT, Shahwan M, Aatif M. Origin of antibiotics and antibiotic resistance, and their impacts on drug development: a narrative review. Pharmaceuticals 2023;16:1615. DOI: https://doi.org/10.3390/ph16111615
Shaikh S, Fatima J, Shakil S, et al. Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. Saudi J Biol Sci 2015;22:90-101. DOI: https://doi.org/10.1016/j.sjbs.2014.08.002
Ethics Approval
The study was approved by the Institutional Ethics Committee (IEC) of NEIGRIHMS, Shillong as documented in the approval letter (Ref No. NEIGR/IEC/M10/T12/2020).How to Cite
“Study of the Clinical Profile of Community-Acquired Pneumonia: A Cross-Sectional Study in Northeast India”. 2025. Monaldi Archives for Chest Disease, June. https://doi.org/10.4081/monaldi.2025.3549.
Copyright (c) 2025 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.